HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Poly(adenosine diphosphate-ribose) synthetase inhibitor 3-aminobenzamide alleviates cochlear dysfunction induced by transient ischemia.

Abstract
The present study was undertaken to determine the possible deleterious role played by poly(adenosine diphosphate-ribose) synthetase (PARS) in cochlear ischemia-reperfusion injury. Transient ischemia of the cochlea was induced in albino guinea pigs for 15, 30, or 60 minutes by pressing the labyrinthine artery at the porus acusticus internus. The animals were given intravenous 3-aminobenzamide (a PARS inhibitor) or physiological saline solution I minute before the onset of reperfusion. The compound action potential thresholds were measured before the onset of ischemia and 4 hours after the onset of reperfusion. A statistically significant reduction in the postischemic compound action potential threshold shift was observed in the animals treated with 3-aminobenzamide after 15 or 30 minutes of ischemia, whereas no statistical difference was found after 60 minutes of ischemia. These results suggest that excessive activation of PARS exerts deleterious effects on the cochlear injury induced by transient ischemia.
AuthorsK Tabuchi, Z Ito, S Tsuji, A Nakagawa, F Serizawa, A Hara, J Kusakari
JournalThe Annals of otology, rhinology, and laryngology (Ann Otol Rhinol Laryngol) Vol. 110 Issue 2 Pg. 118-21 (Feb 2001) ISSN: 0003-4894 [Print] United States
PMID11219517 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Benzamides
  • Poly(ADP-ribose) Polymerase Inhibitors
  • 3-aminobenzamide
  • Poly(ADP-ribose) Polymerases
Topics
  • Action Potentials
  • Analysis of Variance
  • Animals
  • Auditory Threshold
  • Benzamides (pharmacology, therapeutic use)
  • Blood Flow Velocity (drug effects)
  • Cochlea (blood supply)
  • Disease Models, Animal
  • Drug Evaluation, Preclinical
  • Guinea Pigs
  • Poly(ADP-ribose) Polymerase Inhibitors
  • Poly(ADP-ribose) Polymerases (physiology)
  • Reperfusion Injury (drug therapy, enzymology)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: